Conversely there are clinical data showing that EphB3 and EphB2 expression is significantly reduced in advanced and spread colorectal tumors, suggesting a tumor suppressive function for these receptors [11,27,28]. This evidence concerns the gene EPHB2 and colorectal neoplasm.